Nurofen Cold & Flu

Kraj: Malta

Język: angielski

Źródło: Medicines Authority

Kup teraz

Pobierz Ulotka dla pacjenta (PIL)
25-02-2021

Składnik aktywny:

IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE

Dostępny od:

Reckitt Benckiser Healthcare International Limited Thane Road, Nottingham NG90 2DB, United Kingdom

Kod ATC:

M01BX

INN (International Nazwa):

IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE

Forma farmaceutyczna:

COATED TABLET

Skład:

IBUPROFEN 200 milligram(s) ; PSEUDOEPHEDRINE HYDROCHLORIDE 30 milligram(s)

Typ recepty:

OTC

Dziedzina terapeutyczna:

ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS

Status autoryzacji:

Authorised

Data autoryzacji:

2006-02-28

Ulotka dla pacjenta

                                Reckitt Benckiser
0025 375 article 31 ibup
1.3.1 Package Leaflet
Ibuprofen Pseudoephedrine HCl 200mg 30mg Tablets
Page 1
Reckitt Benckiser
0025 375 article 31 ibup
1.3.1 Package Leaflet
Ibuprofen Pseudoephedrine HCl 200mg 30mg Tablets
Page 2
                                
                                Przeczytaj cały dokument
                                
                            

Charakterystyka produktu

                                Page 1 of 10
SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Nurofen Cold & Flu
Nurofen Sinus Relief
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredients
Quantity
Ibuprofen BP
200mg
Pseudoephedrine
Hydrochloride
30mg
3
PHARMACEUTICAL FORM
Yellow film coated tablet. Printed in black with an identifying motif.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the relief of symptoms cold and 'flu with associated congestion,
including
aches and pains, headache, fever, sore throat, blocked nose and
sinuses.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For oral administration and short-term use only.
Adults, the elderly and children over 12 years:
Undesirable effects may be minimised by using the lowest effective
dose for
the shortest duration necessary to control symptoms (see section 4.4).
The patient should consult a doctor if symptoms persist or worsen, or
if the
product is required for more than 10 days.
Take 1 or 2 tablets with water, up to three times a day as required.
Leave at least 4 hours between doses.
Do not take more than 6 tablets in any 24 hour period.
Page 2 of 10
Not to be given to children under 12 years.
4.3
CONTRAINDICATIONS
Hypersensitivity to ibuprofen or any of the excipients in the product.
Patients who have previously shown hypersensitivity reactions (e.g.
asthma,
rhinitis, angioedema, or urticaria) in response to aspirin or other
non-steroidal
anti-inflammatory drugs.
Active or history of recurrent peptic ulcer/haemorrhage (two or more
distinct
episodes of proven ulceration or bleeding).
History of gastrointestinal bleeding or perforation, related to
previous NSAIDs
therapy.
Severe heart failure (NYHA Class IV), renal failure or hepatic failure
(see
section 4.4)
Last trimester of pregnancy (see section 4.6)
Patients with serious cardiovascular disease, tachycardia,
hypertension, angina
pectoris,
hyperthyroidism,
diabetes,
phaeochromocytoma,
closed
angle
glaucoma, prostatic enlargement.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Undesirable effects may be minimi
                                
                                Przeczytaj cały dokument
                                
                            

Zobacz historię dokumentów